| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.578 | 73.829 | 109.608 | 129.568 | 174.294 | 266.874 | 499.075 | 647.048 | 621.269 | 761.966 |
| Total Income - EUR | 25.640 | 75.498 | 113.293 | 131.614 | 179.255 | 281.718 | 514.960 | 674.628 | 629.316 | 759.191 |
| Total Expenses - EUR | 18.947 | 50.168 | 74.021 | 103.526 | 160.997 | 276.923 | 425.043 | 448.393 | 586.821 | 703.651 |
| Gross Profit/Loss - EUR | 6.693 | 25.330 | 39.272 | 28.088 | 18.258 | 4.795 | 89.917 | 226.235 | 42.495 | 55.540 |
| Net Profit/Loss - EUR | 5.925 | 23.110 | 36.488 | 26.774 | 16.466 | 1.982 | 85.129 | 219.624 | 37.984 | 48.042 |
| Employees | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dermaspa Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 2.316 | 96.259 | 102.582 | 100.474 | 148.990 | 176.511 | 207.054 | 169.603 |
| Current Assets | 25.734 | 51.066 | 114.738 | 131.540 | 115.887 | 110.116 | 173.717 | 177.543 | 135.519 | 101.167 |
| Inventories | 16.615 | 33.105 | 74.164 | 97.397 | 67.086 | 9.390 | 5.974 | 88.004 | 15.784 | 24.732 |
| Receivables | 3.779 | 9.502 | 18.794 | 6.860 | 10.476 | 28.465 | 25.141 | 47.951 | 24.004 | 35.620 |
| Cash | 5.340 | 8.459 | 21.780 | 27.283 | 38.325 | 72.261 | 142.601 | 41.589 | 95.732 | 40.816 |
| Shareholders Funds | 5.878 | 28.928 | 64.927 | 90.509 | 105.223 | 105.210 | 188.006 | 250.861 | 266.856 | 168.812 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 19.856 | 22.137 | 52.128 | 137.291 | 113.440 | 105.380 | 135.078 | 103.570 | 76.093 | 102.333 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4645 - 4645" | |||||||||
| CAEN Financial Year |
4645
|
|||||||||
Comments - Dermaspa Srl